When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Lantern Pharma (LTRN) has filed to raise $28.75 million in an IPO of its common stock, according to an S-1 registration statement.
The firm is developing a pipeline of drug candidates for the treatment of prostate, lung and other cancers.
LTRN seeks to use its proprietary AI platform to better identify existing or past failed drug programs that may be repurposed or otherwise enhanced to achieve development success.
I’ll provide an opinion when we learn more IPO details from management.